Sort
40,608 grants matching “prostate cancer”
Genome-wide Pleiotropy Scan across Multiple Cancers
$648,968John S Witte · University Of California, San Francisco · R01 · FY2017 · CA
Night Shift Work and Hormone Levels in Men
$648,881Scott Davis · Fred Hutchinson Cancer Research Center · R01 · FY2008 · CA
Quantitative MRI to automatically delineate intraprostatic tumor for radiation therapy
$648,830Kun Qing · Beckman Research Institute/City Of Hope · R01 · FY2025 · CA
SArcopenia in Men with Prostate Cancer undergoing ADT (SAP-ADT)
$648,806Jose M. Garcia · Seattle Inst For Biomedical/Clinical Res · R01 · FY2025 · CA
Risk prediction methods
$648,755Mitchell H Gail · Division Of Cancer Epidemiology And Genetics · ZIA · FY2013 · CA
Longitudinal Proteomic and Metabolomic Predictors of Pancreatic Cyst Malignant Progression and Early Stage Pancreatic Cancer
$648,753Christian Maximillian Schmidt · Indiana University Indianapolis · U01 · FY2022 · CA
SLCO2B1 AND SLCO1B3 AS NEW TARGETS FOR ENHANCING ANDROGEN DEPRIVATION THERAPY FOR PROSTATE CANCER
$648,750Dana-Farber Cancer Institute, Inc. · · FY2014 · Department of the Army
Role of Shh in developmental patterning and growth of digit skeleton
$648,739Susan Mackem · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Vaccine and Drug Combination Therapy for Human Cancers
$648,692James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Vaccine and radiation for the therapy of human cancers
$648,692James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Evaluation of genetic, clinical and environmental risk factors to establish effective screening strategies for second primary lung cancer
$648,460Summer S Han · Stanford University · R37 · FY2023 · CA
Prostate cancer risk stratification via computational 3D pathology
$648,439Jonathan T.c. Liu · Stanford University · R01 · FY2025 · CA
Proteasome inhibitors against mucosal protozoan pathogens
$648,435Lars Eckmann · University Of California, San Diego · R01 · FY2022 · AI
Proteasome inhibitors against mucosal protozoan pathogens
$648,435Lars Eckmann · University Of California, San Diego · R01 · FY2023 · AI
Proteasome inhibitors against mucosal protozoan pathogens
$648,435Lars Eckmann · University Of California, San Diego · R01 · FY2024 · AI
Proteasome inhibitors against mucosal protozoan pathogens
$648,435Lars Eckmann · University Of California, San Diego · R01 · FY2021 · AI
Proteasome inhibitors against mucosal protozoan pathogens
$648,435Lars Eckmann · University Of California, San Diego · R01 · FY2025 · AI
Multidiciplinary Integrative Genomic Approach to Distinguish Lethal from Indolent Prostate Cancer in Men of Europena and African Ancestry
$648,412Kenneth J. Pienta · Johns Hopkins University · U01 · FY2020 · CA
Novel Androgen Receptor Degraders to Treat Castration-Resistant Prostate Cancer
$648,400Ian Taylor · Arvinas, Inc. · R44 · FY2016 · CA
Longitudinal Proteomic and Metabolomic Predictors of Pancreatic Cyst Malignant Progression and Early Stage Pancreatic Cancer
$648,229Christian Maximillian Schmidt · Indiana University Indianapolis · U01 · FY2023 · CA
PALS: Prostate Cancer Active Lifestyle Study
$648,228Jonathan L. Wright · Fred Hutchinson Cancer Research Center · R01 · FY2016 · CA
Tissue Processing-Sequencing Facility
$648,227Cathy D Vocke · Division Of Basic Sciences - Nci · ZIC · FY2016 · CA
Identifying Cancer Recurrence with Novel Data Linkages with a Cancer Registry
$648,152Jennifer A. Doherty · Utah State Higher Education System--University Of Utah · R01 · FY2025 · CA
Next Gen Targeted nanoparticles for Inhibiting Gli2 in Bone Metastatic Tumors
$648,024Julie A Sterling · Vanderbilt University Medical Center · R01 · FY2025 · CA
Clinical and Analytical Validation of Cancer Biomarkers
$648,000Daniel W Chan · Johns Hopkins University · U24 · FY2016 · CA